• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Lamivudine-resistant hepatitis B virus and ongoing lamivudine therapy: Stop the merry-go-round, it's time to get off!

P Angus, S Locarnini

Antiviral Therapy | INT MEDICAL PRESS LTD | Published : 2004

DOI: 10.1177/135965350400900205

University of Melbourne Researchers

Peter Angus's Profile Picture
Peter Angus Author

Citation metrics

15Scopus
14Web of Science
15Dimensions

Keywords

Motif Mutation
Chronic Liver Disease and Cirrhosis
Mutants
3207 Medical Microbiology
Adefovir Dipivoxil
Polymerase
Surveillance
3 Good Health and Well Being
Long-Term Lamivudine
Digestive Diseases
Replication
Life Sciences & Biomedicine
Liver Disease
Chemotherapy
Hepatitis - B
Hbv
Hepatitis - C
32 Biomedical and Clinical Sciences
Emerging Infectious Diseases
Pharmacology & Pharmacy
Emergence
Hepatitis
Science & Technology
Infectious Diseases
Virology

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224